Aurobindo Pharma Limited (BOM:524804)
India · Delayed Price · Currency is INR 1,391.15
+23.45 (1.71%)
At close: Apr 21, 2026
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 808.3 billion as of April 22, 2026. Its market cap has increased by 20.24% in one year.
Market Cap
808.30B
Enterprise Value
797.25B
Revenue
331.82B
Ranking
n/a
PE Ratio
23.18
Stock Price
1,391.15
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 808.30B, an increase of 8,316.94%. That is a compound annual growth rate of 20.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 794.42B | 15.62% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.42T |
| Lupin | 1.06T |
| Dr. Reddy's Laboratories | 1.03T |
| Abbott India | 543.53B |
| GlaxoSmithKline Pharmaceuticals | 412.01B |
| J. B. Chemicals & Pharmaceuticals | 319.99B |
| AstraZeneca Pharma India | 213.00B |
| Granules India | 164.48B |